Download PDF
Thromb Haemost 1999; 81(04): 538-542
DOI: 10.1055/s-0037-1614520
Rapid Communication
Schattauer GmbH

Haemostatic, Endothelial and Lipoprotein Parameters and Blood Pressure Levels in Women with a History of Preeclampsia

Shu He
1   From the Department of Laboratory Medicine/Coagulation Research, Karolinska Institutet, Karolinska Hospital, Stockholm, Sweden
,
Angela Silveira
3   Atherosclerosis Research Unit, King Gustaf V Research Institute, Karolinska Institutet, Karolinska Hospital, Stockholm, Sweden
,
Anders Hamsten
3   Atherosclerosis Research Unit, King Gustaf V Research Institute, Karolinska Institutet, Karolinska Hospital, Stockholm, Sweden
,
Margareta Blombäck
1   From the Department of Laboratory Medicine/Coagulation Research, Karolinska Institutet, Karolinska Hospital, Stockholm, Sweden
,
Katarina Bremme
2   Department of Woman and Child Health and Karolinska Institutet, Karolinska Hospital, Stockholm, Sweden
› Author Affiliations
Further Information

Publication History

Received 06 July 1998

Accepted after resubmission 17 December 1998

Publication Date:
09 December 2017 (online)

Also available at
    Permissions and Reprints

Summary

To determine whether perturbations of haemostatic function and lipoprotein metabolism prevail long after preeclampsia and increase the risk of future coronary heart disease (CHD), we conducted a follow-up study in women with (cases, n = 25) or without (controls, n = 24) a history of preeclampsia. Blood samples were taken in the follicular and in the luteal phases of a menstrual cycle. Levels of blood pressure (BP) and proteinuria measured during the index pregnancy were included in the evaluation. Compared to control women who had undergone a normal pregnancy, the formerly preeclamptic patients had higher systolic (p <0.01) and diastolic (p <0.05) BPs and increased plasma levels of von Willebrand factor (vWF), fibrinogen, cholesterol, triglycerides and very low density lipoprotein (VLDL) (all p <0.05). The lipid, vWF, and fibrinogen levels were positively related to the degree of BP elevation but not to the degree of proteinuria during the index pregnancy. Except for the increase in vWF level, all biochemical perturbations were only present in the luteal but not in the follicular phase samples. In conclusion, persistent endothelial dysfunction with ensuing dysregulation of blood pressure, haemostatic perturbation and dyslipoproteinemia after preeclampsia may indicate a proneness to future CHD.

 

  • References

  • 1 Greer IA. Pathological Processes in Pregnancy-induced Hypertension and Intrauterine Growth retardation: “An Excess of Heated Blood”. In Haemostasis and Thrombosis in Obstetrics and Gynecology. Greer IA, Turpie AGG, Forbes CD. eds. London: Chapman & Hall Medical; 1992: 163-202.
    Search in Google Scholar
  • 2 Deng L, Bremme K, Hansson LO, Blombäck M. Plasma levels of von Willebrand factor and fibronectin as markers of persisting endothelial damage in preeclampsia. Obstet Gynecol 1994; 84: 941-5.
    PubMedSearch in Google Scholar
  • 3 He S, Bremme K, Blombäck M. Acquired deficiency of antithrombin in association with a hypercoagulable state and impaired function of liver and/or kidney in preeclampsia. Blood Coag Fibrinol 1997; 8: 232-8.
    CrossrefPubMedSearch in Google Scholar
  • 4 Hubel CA, McLaughlin MK, Evans RW, Hauth BA, Sims CJ, Roberts JM. Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum. Am J Obstet Gynecol 1996; 174: 975-82.
    CrossrefPubMedSearch in Google Scholar
  • 5 Sattar N, Bendomir A, Berry C, Shepherd J, Greer IA, Packard CJ. Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis. Obstet Gynecol 1997; 89: 403-8.
    CrossrefPubMedSearch in Google Scholar
  • 6 Sibai BM, Mercer B, Sarinoglu C. Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis. Am J Obstet Gynecol 1991; 165: 1408-12.
    CrossrefPubMedSearch in Google Scholar
  • 7 Svensson A, Andersch B, Hansson L. Prediction of later hypertension following a hypertensive pregnancy. J Hypert 1983; 1: 94-6.
    PubMedSearch in Google Scholar
  • 8 Jonsdottir LS, Arngrimsson R, Geirsson RT, Sigvaldason H, Sigfusson N. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand 1995; 74: 772-6.
    CrossrefPubMedSearch in Google Scholar
  • 9 Makris TK, Tsoukala C, Krespi P, Hatzizacharias A, Gialeraki A, Papargyriou J, Votteas V, Mandalaki T. Haemostasis balance disorders in patients with essential hypertension. Thromb Res 1997; 88: 99-107.
    CrossrefPubMedSearch in Google Scholar
  • 10 Ossei-Gerning N, Wilson IJ, Grant WP. Sex differences in coagulation and fibrinolysis in subjects with coronary artery disease. Thromb Haemost 1998; 79: 736-40.
    Thieme ConnectPubMedSearch in Google Scholar
  • 11 Moor E, Hamsten A, Blombäck M, Herzfeld I, Wiman B, Ryden L. Haemostatic factors and inhibitors and coronary artery bypass grafting: preoperative alterations and relations to graft occlusion. Thromb Haemost 1994; 72: 335-42.
    Thieme ConnectPubMedSearch in Google Scholar
  • 12 Moor E, Silveira A, van’t Hooft F, Suontaka AM, Eriksson P, Blombäck M, Hamsten A. Coagulation factor VII mass and activity in young men with myocardial infarction at a young age. Role of plasma lipoproteins and factor VII genotype. Arterioscler Thromb Vasc Biol 1995; 15: 655-64.
    CrossrefPubMedSearch in Google Scholar
  • 13 Catalano M, Perilli E, Carzaniga G, Colombo F, Carotta M, Andreoni S. Lp(a) in hypertensive patients. J Human Hypert 1998; 12: 83-9.
    PubMedSearch in Google Scholar
  • 14 Krauss RM. Atherogenicity of triglyceride-rich lipoproteins. Am J Cardiol 1998; 81: 13-7.
    PubMedSearch in Google Scholar
  • 15 Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol 1998; 81: 7-12.
    CrossrefPubMedSearch in Google Scholar
  • 16 Blombäck M, Eneroth P, Landgren BM, Lagerström M, Anderson O. On the intraindividual and gender variability of haemostatic components. Thromb Haemost 1992; 67: 70-5.
    Thieme ConnectPubMedSearch in Google Scholar
  • 17 Andersson O, Blombäck M, Bremme K, Wramsby H. Prediction of changes in levels of haemostatic variables during natural menstrual cycle and ovarian hyperstimulation. Thromb Haemost 1997; 77: 901-4.
    Thieme ConnectPubMedSearch in Google Scholar
  • 18 Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988; 158: 892-8.
    CrossrefPubMedSearch in Google Scholar
  • 19 Clauss A. Gerinungsphysiologische Schnellmethode. Zur Bestimmung des Fibrinogens. Acta Haemat 1957; 5: 237-46.
    PubMedSearch in Google Scholar
  • 20 Silveira A, Yamamoto T, Adamson L, Hessel B, Blombäck B. Application of an enzyme-linked immunosorbent assay (ELISA) to von Willebrand factor (vFW) and its derivatives. Thromb Res 1986; 43: 91-102.
    CrossrefPubMedSearch in Google Scholar
  • 21 Silveira A, Green F, Karpe F, Blombäck M, Humphries S, Hamsten A. Elevated levels of factor VII activity in the postprandial state: effect of the factor VII Arg-Gln polymorphism. Thromb Haemost 1994; 72: 734-9.
    Thieme ConnectPubMedSearch in Google Scholar
  • 22 Morrissey JH, Macik BG, Neuenschwander PF, Comp PC. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 1993; 81: 734-44.
    PubMedSearch in Google Scholar
  • 23 Chmielewska J, Wiman B. Determination of tissue plasminogen activator and its “fast” inhibitor in plasma. Clin Chem 1986; 32: 482-5.
    PubMedSearch in Google Scholar
  • 24 Korninger C, Speiser W, Wojta J, Binder BR. Sandwich ELISA for t-PA antigen employing a monoclonal antibody. Thromb Res 1986; 41: 527-35.
    CrossrefPubMedSearch in Google Scholar
  • 25 Doolittle RF. Fibrinogen and Fibrin. In Haemostasis and Thrombosis. Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD. eds. Edinburgh: Churchill Livingstone; 1994: 491-513.
    Search in Google Scholar
  • 26 Ludlam CA. Assessement of Platelet Fuction. In Haemostasis and Thrombosis. Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD. eds. Edinburgh: Churchill Livingstone; 1994: 199-215.
    Search in Google Scholar
  • 27 Lowe GD, Rumley A, Tooke J. Clinical pathophysiology of arterial disease. In A Textbook of Vascular Medicine. Tooke J, Lowe GD. eds. London: Arnold; 1996: 43-59.
    Search in Google Scholar
  • 28 Whelton PK. Epidemiology of hypertension. Lancet 1994; 344: 101-6.
    CrossrefPubMedSearch in Google Scholar
  • 29 National High Blood Pressure Education Program Working Group Report on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 1990; 163: 1689-712.
    PubMedSearch in Google Scholar
  • 30 Redman CWG. Hypertension in pregnancy. In Medical Disorders in Obstetric Practice. de Swiet M. ed. London: Blackwell Scince; 1995: 182-225.
    Search in Google Scholar
  • 31 Redman CWG, Roberts JM. Management of preeclampsia. Lancet 1993; 341: 1451-4.
    CrossrefPubMedSearch in Google Scholar
  • 32 Lindheimer MD. Hypertension in pregnancy. Hypertension 1993; 22: 127-37.
    CrossrefPubMedSearch in Google Scholar
  • 33 Sullivan CA, Magann EF, Perry JR KG, Roberts WE, Blake PG, Martin JR JN. The recurrence risk of the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP) in subsequent gestations. Am J Obstetr Gynecol 1994; 171: 940-3.
    CrossrefPubMedSearch in Google Scholar
  • 34 Mehta L, Young ID. Recurrence risks for common complications of pregnancy – a review. Obstet Gynecol Survey 1987; 42: 218-23.
    CrossrefPubMedSearch in Google Scholar